Your browser doesn't support javascript.
loading
Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda.
Kanoi, Bernard N; Takashima, Eizo; Morita, Masayuki; White, Michael T; Palacpac, Nirianne M Q; Ntege, Edward H; Balikagala, Betty; Yeka, Adoke; Egwang, Thomas G; Horii, Toshihiro; Tsuboi, Takafumi.
Afiliación
  • Kanoi BN; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Ehime 790-8577, Japan.
  • Takashima E; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Ehime 790-8577, Japan. Electronic address: takashima.eizo.mz@ehime-u.ac.jp.
  • Morita M; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Ehime 790-8577, Japan.
  • White MT; Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia; MRC Center for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.
  • Palacpac NM; Department of Molecular Protozoology, Research Institute for Microbial Diseases, Osaka University, Suita 565-0871, Japan.
  • Ntege EH; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Ehime 790-8577, Japan.
  • Balikagala B; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Ehime 790-8577, Japan.
  • Yeka A; Makerere University College of Health Sciences, School of Public Health, Kampala, Uganda.
  • Egwang TG; Med Biotech Laboratories, Plot 4-6 Bell Close, Port Bell Road Luzira, Kampala, Uganda.
  • Horii T; Department of Molecular Protozoology, Research Institute for Microbial Diseases, Osaka University, Suita 565-0871, Japan.
  • Tsuboi T; Division of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Ehime 790-8577, Japan. Electronic address: tsuboi.takafumi.mb@ehime-u.ac.jp.
Vaccine ; 35(6): 873-881, 2017 02 07.
Article en En | MEDLINE | ID: mdl-28089547
The key targets of protective antibodies against Plasmodium falciparum remain largely unknown. In this study, we determined immunoreactivity to 1827 recombinant proteins derived from 1565 genes representing ∼30% of the entire P. falciparum genome, for identification of novel malaria vaccine candidates. The recombinant proteins were expressed by wheat germ cell-free system, a platform that can synthesize quality plasmodial proteins that elicit biologically active antibodies in animals. Sera were obtained from indigenous residents of a malaria endemic region in Northern Uganda who were enrolled at the start of a rainy season and prospectively monitored for symptomatic malaria episodes for a year. Immunoreactivity to sera was determined by AlphaScreen; a homogeneous high-throughput system that detects protein interactions. Our analysis revealed antibody responses to 128 proteins that significantly associated with protection from symptomatic malaria. From 128 proteins, 53 were down-selected as the most plausible targets of host protective immune response by virtue of having a predicted signal peptide and/or transmembrane domain(s), or confirmed localization on the parasite surface. The 53 proteins comprised of not only previously characterized vaccine candidates but also uncharacterized proteins. Proteins involved in erythrocyte invasion; RON4, RON2 and CLAG3.1 and pre-erythrocytic proteins; SIAP-2, TRAP and CelTOS, were recommended for prioritization for further evaluation as vaccine candidates. The findings clearly demonstrate that generation of the protein library using the wheat germ cell-free system coupled with high throughput immunoscreening with AlphaScreen offers new options for rational discovery and selection of potential malaria vaccine candidates.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Plasmodium falciparum / Proteínas Protozoarias / Malaria Falciparum / Vacunas contra la Malaria / Genoma de Protozoos / Resistencia a la Enfermedad / Antígenos de Protozoos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adolescent / Adult / Child / Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: Vaccine Año: 2017 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Plasmodium falciparum / Proteínas Protozoarias / Malaria Falciparum / Vacunas contra la Malaria / Genoma de Protozoos / Resistencia a la Enfermedad / Antígenos de Protozoos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adolescent / Adult / Child / Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: Vaccine Año: 2017 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos